Cediranib Maleate and Olaparib in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Peritoneal Cancer or Recurrent Triple-Negative Breast Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Pfizer
Numab Therapeutics AG
ADC Therapeutics S.A.
pharmaand GmbH
Tesaro, Inc.
Alliance for Clinical Trials in Oncology
Takeda
Masonic Cancer Center, University of Minnesota
National Cancer Institute (NCI)
INSYS Therapeutics Inc
Case Comprehensive Cancer Center